[Pubmed] What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?
Posté : 15 sept. 2022 12:00
Expert Opin Pharmacother. 2022 Sep 14:1-4. doi: 10.1080/14656566.2022.2122710. Online ahead of print.
NO ABSTRACT
PMID:36104973 | DOI:10.1080/14656566.2022.2122710
Source: https://pubmed.ncbi.nlm.nih.gov/3610497 ... 0&v=2.17.8